Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR

26 Nov 2011

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Research Studies
Share to Lung Cancer Treatments and Mutations
Share to Microtubule and mitosis dynamics

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 22124476
DOI: 10.1097/jto.0b013e3182370e30

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFRPMID 22124476Read ↗

The Biology and Clinical Features of Non–small Cell Lung Cancers with EML4-ALK TranslocationSemantic proximity Read ↗

Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancerSemantic proximity Read ↗

Second Primary Lung Adenocarcinoma Harboring EML4-ALK After Surgically Resected EGFR Positive Lung Adenocarcinoma.Semantic proximity Read ↗

The Change in Paradigm for NSCLC Patients with EML4–ALK TranslocationSemantic proximity Read ↗

Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genesSemantic proximity Read ↗

ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancerSemantic proximity Read ↗

Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.Semantic proximity Read ↗

Comparison of clinical characteristics between patients with ALK-positive and EGFR-positive lung adenocarcinoma.Semantic proximity Read ↗

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.Semantic proximity Read ↗

Lung adenocarcinoma harboring concomitant EGFR mutation and EML4-ALK fusion that benefits from three kinds of tyrosine kinase inhibitors: a case report and literature review.Semantic proximity Read ↗

EML4‑ALK fusion gene in non‑small cell lung cancer (Review)Semantic proximity Read ↗

EML4-ALK: Update on ALK InhibitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.